HB 833 — Consultant Pharmacists

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HBCS/HB 833 2019 A bill to be entitled An act relating to pharmacy;consultant pharmacists;

prohibiting a consultant pharmacist from modifying or discontinuing medicinal drugs prescribed by a health care practitioner under certain conditions;

prohibiting a consultant pharmacist from diagnosing any disease or condition;

conforming provisions to changes made by the act;

(13) "Practice of the profession of pharmacy" includes compounding,Page dispensing,1 and consulting concerning contents, therapeutic values, and uses of any6 medicinalCODING: drug;

consulting concerning therapeutic values and interactions of patent or Page 1 of 6 CODING:

hb0833-00hb0833-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HBCS/HB 833 2019 proprietarycompounding, preparations,dispensing, whetherand pursuantconsulting toconcerning prescriptionscontents, ortherapeutic invalues, the absence and entirelyuses independent of suchany prescriptionsmedicinal ordrug; orders;

consulting concerning therapeutic values and interactions of patent or proprietary preparations, whether pursuant to prescriptions or in the absence and entirely independent of such prescriptions or orders;

"Practice of the profession of pharmacy" also includes any other act, service, operation, research, or transaction incidental to, or forming a part of, any of the foregoing acts, requiring, involving, or employing the science or art of any branch of the pharmaceutical profession,Page study,2 orof training,6 andCODING: shall expressly permit a pharmacist to transmit information from persons authorized to prescribe medicinal drugs to their patients.

The practice of the Page 2 of 6 CODING:

hb0833-00hb0833-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HBCS/HB 833 2019 professionprofession, ofstudy, pharmacyor alsotraining, includesand theshall administrationexpressly ofpermit vaccinesa pharmacist to adultstransmit pursuantinformation from persons authorized to s.prescribe medicinal drugs to their patients.

The practice of the profession of pharmacy also includes the administration of vaccines to adults pursuant to s.

(a) A consultant pharmacist may provide medication management services within the framework of a collaborative practice agreement between the pharmacist and a physician licensed under chapter 458 or chapter 459, a podiatric physician licensed under chapter 461, or a dentist licensed under chapter Page 3 of 6 CODING:

hb0833-00hb0833-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HBCS/HB 833 2019 practice agreement between the pharmacist and a health care facility medical director or a physician licensed under chapter 458 or chapter 459, a podiatric physician licensed under chapter 461, or a dentist licensed under chapter 466, who is authorized to prescribe medicinal drugs.

Such(b) A collaborative practice agreement must outline the circumstances under which the consultant pharmacist may:

A consultant pharmacist may not modify or discontinue medicinal drugs prescribed by a health care practitioner who does not have a collaborative practice agreement with the consultant pharmacist.

(b)(c) A The consultant pharmacist shall maintain be responsible for maintaining all drug, patient care, and quality assurance records as required by law and, with the collaborating practitioner, shall maintain collaborative practice agreements that must be available upon request from or upon inspection by thePage department.4 of 6 CODING:

(c) For purposes of this subsection, the term "health care facility" means an ambulatory surgical center or hospital licensed under chapter 395, an alcohol or chemical dependency treatment center licensed under chapter 397, a hospice licensed under part IV of chapter 400, a nursing home licensed under part II of chapter 400, a home health agency licensed under part III Page 4 of 6 CODING:

hb0833-00hb0833-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HBCS/HB 833 2019 ofthe chapterdepartment. 400, an ambulatory care center as defined in s.

408.07,(d) orThis asubsection nursingmay homenot componentbe underconstrued chapterto 400authorize within a continuingconsultant carepharmacist facilityto licenseddiagnose underany chapterdisease 651.or condition.

for(e) establishingFor drugpurposes handlingof proceduresthis forsubsection, the safeterm handling"health andcare storagefacility" means an ambulatory surgical center or hospital licensed under chapter 395, an alcohol or chemical dependency treatment center licensed under chapter 397, an inpatient hospice licensed under part IV of drugs.chapter 400, a nursing home licensed under part II of chapter 400, an ambulatory care center as defined in s.

408.07, or a nursing home component under chapter 400 within a continuing care facility licensed under chapter 651 for establishing drug handling procedures for the safe handling and storage of drugs.

(2) Notwithstanding the provisions of subsection (1), a consultant pharmacist or a doctor of pharmacy licensed in this state may also be responsible for ordering and evaluating any laboratory or clinical testing for persons under the care of a licensed home health agency when, in the judgment of the consultant pharmacist or doctor of pharmacy, such activity is necessary for the proper performance of his or her responsibilities and only when authorized by a practitioner Page 5 of 6 CODING:

hb0833-00hb0833-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HBCS/HB 833 2019 (2) Notwithstanding the provisions of subsection (1), a consultant pharmacist or a doctor of pharmacy licensed in this state may also be responsible for ordering and evaluating any laboratory or clinical testing for persons under the care of a licensed home health agency when, in the judgment of the consultant pharmacist or doctor of pharmacy, such activity is necessary for the proper performance of his or her responsibilities and only when authorized by a practitioner licensed under chapter 458, chapter 459, chapter 461, or chapter 466.

(2)(3)(3) The board shall adopt promulgate rules necessary to implement and administer this section.

hb0833-00hb0833-01-c1